Observational study links semaglutide dose and weight loss to lower liver disease risk.
Study links semaglutide use to lower risk of several liver conditions in patients with liver disease
This observational study from a real-world federated EHR network analyzed 6,734 patients with liver disease. It found associations between h…
Higher semaglutide doses and greater weight loss were linked to lower risks of steatohepatitis, alcoholic liver disease, and death in patien…
Oyster-derived bioactives show hepatoprotective effects in animal models of alcoholic liver disease
Could oyster compounds help protect the liver from alcohol damage?
A systematic review and meta-analysis of 11 studies (10 animal, 1 human trial) found oyster-derived compounds reduced liver enzymes by 34-56…
Oyster compounds may protect the liver from alcohol damage in animals by lowering injury markers and boosting antioxidant defenses, though h…